Polyphenols including catechin from green tea with in vitro antiviral activity exhibited anti-herpes simplex virus activity but not anti-influenza virus activity in mice

Journal of Traditional Medicines

Volumn 28, Issue 2, 2011, Pages 63-72

  Daikoku, Tohru ^a   Horiba, Kazuhiro ^a   Miyata, Kei ^a   Takemoto, Masaya ^a   Okuda, Tomoko ^a   Yoshida, Yoshihiro ^a   Sawamura, Rie ^b   Imakita, Masami ^c   Okubo, Tsutomu ^d   Nagaura, Yoshiaki ^e   Kurokawa, Masahiko ^b   Shiraki, Kimiyasu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b KYUSHU UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^c Department of Cardiology   (Japan)

^d TAIYO KAGAKU CO LTD   (Japan)

^e Nagaura Lab Co Inc   (Japan)

Author keywords

catechin; green tea; herpes simplex virus; medicinal herb; therapeutic efficacy

Indexed keywords

EID: 84882871627     PISSN: 18801447     EISSN: 18813747     Source Type: Journal    
DOI: 10.11339/jtm.28.63     Document Type: Article

References (34)

1. Kurokawa, M., Basnet, P., Ohsugi, M., Hozumi, T., Kadota, S., Namba, T., Kawana, T. and Shiraki, K.: Anti-herpes simplex virus activity of moronic acid purified from Rhus javanica in vitro and in vivo. J. Pharmacol. Exp. Ther., 289, 72-78, 1999.
2. Kurokawa, M., Hozumi, T., Tsurita, M., Kadota, S., Namba, T. and Shiraki, K.: Biological characterization of eugeniin as an anti-herpes simplex virus type 1 compound in vitro and in vivo. J. Pharmacol. Exp. Ther., 297, 372-379, 2001.
3. Kurokawa, M., Hozumi, T., Basnet, P., Nakano, M., Kadota, S., Namba, T., Kawana, T. and Shiraki, K.: Purification and characterization of eugeniin as an anti-herpesvirus compound from Geum japonicum and Syzygium aromaticum. J. Pharmacol. Exp. Ther., 284, 728-735, 1998.
4. Kurokawa, M., Yamamura, J., Li, Z., Sato, H., Hitomi, N., Tatsumi, Y. and Shiraki, K.: Antipyretic activity of cinnamyl derivatives and related compounds in influenza virus-infected mice. Eur. J. Pharmacol., 348, 45-51, 1998.
5. Kurokawa, M., Nakano, M., Ohyama, H., Hozumi, T., Kageyama, S., Namba, T. and Shiraki, K.: Prophylactic efficacy of traditional herbal medicines against recurrent herpes simplex virus type 1 infection from latently infected ganglia in mice. J. Dermatol. Sci., 14, 76-84, 1997.
6. Kurokawa, M., Ochiai, H., Nagasaka, K., Neki, M., Xu, H., Kadota, S., Sutardjo, S., Matsumoto, T., Namba, T. and Shiraki, K.: Antiviral traditional medicines against herpes simplex virus (HSV-1), poliovirus, and measles virus in vitro and their therapeutic efficacies for HSV-1 infection in mice. Antiviral Res., 22, 175-188, 1993.
7. Kurokawa, M., Ohyama, H., Hozumi, T., Namba, T., Nakano, M. and Shiraki, K.: Assay for antiviral activity of herbal extracts using their absorbed sera. Chem. Pharm. Bull. (Tokyo), 44, 1270-1272, 1996.
8. Kurokawa, M., Tsurita, M., Brown, J., Fukuda, Y. and Shiraki, K.: Effect of interleukin-12 level augmented by Kakkon-to, a herbal medicine, on the early stage of influenza infection in mice. Antiviral Res., 56, 183-188, 2002.
9. Kurokawa, M., Watanabe, W., Shimizu, T., Sawamura, R. and Shiraki, K.: Modulation of cytokine production by 7-hydroxycoumarin in vitro and its efficacy against influenza infection in mice. Antiviral Res., 85, 373-380, 2010.
10. Kurokawa, M., Kumeda, C. A., Kamamura, J., Kamiyama, T. and Shiraki, K.: Antipyretic activity of gingyo-san, a traditional medicine, in influenza virus-infected mice. Chem. Pharm. Bull. (Tokyo), 46, 1444-1447, 1998.
11. Nagasaka, K., Kurokawa, M., Imakita, M., Terasawa, K. and Shiraki, K.: Efficacy of kakkon-to, a traditional herb medicine, in herpes simplex virus type 1 infection in mice. J. Med. Virol., 46, 28-34, 1995.
12. Chuanasa, T., Phromjai, J., Lipipun, V., Likhitwitayawuid, K., Suzuki, M., Pramyothin, P., Hattori, M. and Shiraki, K.: Anti-herpes simplex virus (HSV-1) activity of oxyresveratrol derived from Thai medicinal plant: mechanism of action and therapeutic efficacy on cutaneous HSV-1 infection in mice. Antiviral Res., 80, 62-70, 2008.
13. Lipipun, V., Kurokawa, M., Suttisri, R., Taweechotipatr, P., Pramyothin, P., Hattori, M. and Shiraki, K.: Efficacy of Thai medicinal plant extracts against herpes simplex virus type 1 infection in vitro and in vivo. Antiviral Res., 60, 175-180, 2003.
14. Kurokawa, M., Brown, J., Kagawa, Y. and Shiraki, K.: Cytokine-regulatory activity and therapeutic efficacy of cinnamyl derivatives in endotoxin shock. Eur. J. Pharmacol., 474, 283-293, 2003.
15. Kurokawa, M., Imakita, M., Kumeda, C. A. and Shiraki, K.: Cascade of fever production in mice infected with influenza virus. J. Med. Virol. 50, 152-158, 1996.
16. Kaul, T. N., Middleton, E., Jr. and Ogra, P. L.: Antiviral effect of flavonoids on human viruses. J. Med. Virol., 15, 71-79, 1985.
17. Ferrea, G., Canessa, A., Sampietro, F., Cruciani, M. and Romussi, G., Bassetti, D.: In vitro activity of a Combretum micranthum extract against herpes simplex virus types 1 and 2. Antiviral Res., 21, 317-325, 1993.
18. Nakane, H. and Ono, K.: Differential inhibitory effects of some catechin derivatives on the activities of human immunodeficiency virus reverse transcriptase and cellular deoxyribonucleic and ribonucleic acid polymerases. Biochemistry, 29, 2841-2845, 1990.
19. Yamaguchi, K., Honda, M., Ikigai, H., Hara, Y. and Shimamura, T.: Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1). Antiviral Res., 53, 19-34, 2002.
20. Xu, J., Wang, J., Deng, F., Hu, Z. and Wang, H.: Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro. Antiviral Res., 78, 242-249, 2008.
21. Weber, J. M., Ruzindana-Umunyana, A., Imbeault, L. and Sircar, S.: Inhibition of adenovirus infection and adenain by green tea catechins. Antiviral Res., 58, 167-173, 2003.
22. Tichopad, A., Polster, J., Pecen, L. and Pfaffl, M. W.: Model of inhibition of Thermus aquaticus polymerase and Moloney murine leukemia virus reverse transcriptase by tea polyphenols (+)-catechin and (-)-epigallocatechin-3-gallate. J. Ethnopharmacol., 99, 221-227, 2005.
23. Mantani, N., Imanishi, N., Kawamata, H., Terasawa, K. and Ochiai, H.: Inhibitory effect of (+)-catechin on the growth of influenza A/PR/8 virus in MDCK cells. Planta. Med., 67, 240-243, 2001.
24. Song, J. M., Lee, K. H. and Seong, B. L.: Antiviral effect of catechins in green tea on influenza virus. Antiviral Res., 68, 66-74, 2005.
25. Song, J. M., Park, K. D., Lee, K. H., Byun, Y. H., Park, J. H., Kim, S. H., Kim, J. H. and Seong, B. L.: Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives. Antiviral Res., 76, 178-185, 2007.
26. Barnard, D. L., Smee, D. F., Huffman, J. H., Meyerson, L. R. and Sidwell, R. W.: Antiherpesvirus activity and mode of action of SP-303, a novel plant flavonoid. Chemotherapy, 39, 203-211, 1993.
27. Furuta, Y., Takahashi, K., Fukuda, Y., Kuno, M., Kamiyama, T., Kozaki, K., Nomura, N., Egawa, H., Minami, S., Watanabe, Y., Narita, H. and Shiraki, K.: In vitro and in vivo activities of anti-influenza virus compound T-705. Antimicrob. Agents Chemother., 46, 977-981, 2002.
28. Furuta, Y., Takahashi, K., Kuno-Maekawa, M., Sangawa, H., Uehara, S., Kozaki, K., Nomura, N., Egawa, H. and Shiraki, K.: Mechanism of action of T-705 against influenza virus. Antimicrob. Agents Chemother., 49, 981-986, 2005.
29. Okuda, T., Kurokawa, M., Matsuo, K., Honda, M., Niimura, M. and Shiraki, K.: Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus. J. Med. Virol., 72, 112-120, 2004.
30. Yoshida, Y., Li, Z., Kurokawa, M., Kawana, T., Imakita, M. and Shiraki, K.: Growth of herpes simplex virus in epidermal keratinocytes determines cutaneous pathogenicity in mice. J. Med. Virol., 75, 421-426, 2005.
31. Yokozawa, T., Oura, H., Iwano, M., Dohi, K. and Hattori, M.: Inhibitory effects of crude drug components on the proliferation of cultured human mesangial cells. Nippon Jinzo Gakkai Shi 35, 321-327, 1993.
32. Nakayama, M., Suzuki, K., Toda, M., Okubo, S., Hara, Y. and Shimamura, T.: Inhibition of the infectivity of influenza virus by tea polyphenols. Antiviral Res., 21, 289-299, 1993.
33. Oxford, J. S., Novelli, P., Sefton, A. and Lambkin, R.: New millennium antivirals against pandemic and epidemic influenza: the neuraminidase inhibitors. Antivir. Chem. Chemother., 13, 205-217, 2002.
34. Takahashi, K., Furuta, Y., Fukuda, Y., Kuno, M., Kamiyama, T., Kozaki, K., Nomura, N., Egawa, H., Minami, S. and Shiraki, K.: In vitro and in vivo activities of T-705 and oseltamivir against influenza virus. Antivir. Chem. Chemother., 14, 235-241, 2003.